Alaunos Therapeutics, Inc. (TCRT) Capital expenditures 2016–2025
Alaunos Therapeutics, Inc. (TCRT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$98,000FY2025 · since FY2016: $551,000 → $98,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98,000 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $197,000 | -8.8% |
| FY2022 | $216,000 | -93.5% |
| FY2021 | $3.3M | -66.0% |
| FY2020 | $9.8M | +3343.0% |
| FY2019 | $284,000 | -38.1% |
| FY2018 | $459,000 | -37.7% |
| FY2017 | $737,000 | +33.8% |
| FY2016 | $551,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice